Histogen, Inc.'s Method of Generating Multipotent Stem Cells Receives U.S. Patent

Histogen, Inc., a regenerative medicine company developing innovative therapies for conditions including hair loss and cancer, today announced that the United States Patent & Trademark Office has issued patent 8,524,494, entitled "Low Oxygen Tension and bFGF Generates a Multipotent Stem Cell from a Fibroblast In Vitro" to the Company.

http://www.biospace.com/news_story.aspx?StoryID=307467&full=1